Exhibit 31.2





CERTIFICATIONS





I, Sanding Tao, certify that:





1. I have reviewed this report on Form
10-Q for the quarter ended March 31, 2008 of Huifeng Bio-Pharmaceutical
Technology, Inc.;




2. Based on my knowledge, this report
does not contain any untrue statement of a material fact or omit to
statea material fact
necessary to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period covered by
this report;




3. Based on my knowledge, the financial
statements, and other financial information included in this
report, fairly present in all material respects the financial condition, results
of operations and cash flows of the registrant as of, and for, the periods
presented in this report;




4. The registrant's other
certifying officers and I
are responsible for establishing and maintaining disclosure controls and
procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and
internal control over financial reporting (as defined in Exchange Act Rules
13a-15(f) and15d-15(f) for the registrant and
have:




(a) designed such disclosure controls
and procedures, or caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information relating to the
registrant, includingits
consolidated subsidiaries, is made known to us by others within those entities,
particularly during the period in which this report is being
prepared;




(b) designed such internal control over
financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of
financial reporting and the preparation of financial statements, for external
purposes in accordance with generally accepted accounting principles;




(c) evaluated the effectiveness of the
registrant's disclosure controls and procedures and presented in this report our
conclusions about the effectiveness of the disclosure controls and procedures,
as of the end of the period covered by this report based on such evaluation;
and




(d) disclosed in this report any change
in the registrant's internal control over financial reporting that occurred
during the registrant's most recent fiscal quarter (the registrant's fourth
fiscal quarter in the caseof an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting;
and




5. The registrant's other certifying
officer and I have disclosed, based on our most recentevaluation of internal control over
financial reporting, to the registrant's auditors and the audit committee of the
registrant's board of directors (or persons performing the equivalent
functions):




(a) all significant deficiencies and
material weaknesses in the
design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record,
process, summarize and report financial information; and




(b) any fraud, whether or not
material,that involves
management or other employees who have a significant role in the registrant's
internal control over financial reporting.







Date:January20,
2009                                                                By:/s/Sanding
Tao


Sanding Tao


Chief Financial
Officer